Endpoint Ventures - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2015
Endpoint Ventures is an early-stage investment firm specializing in healthcare, life sciences, diagnostics, and therapeutics. The firm typically invests in pre-seed, seed, and Series A rounds, focusing on innovative startups within these sectors. Their investment approach aims to support groundbreaking advancements in medical and scientific fields.
Notable portfolio companies include BillionToOne, FidoCure®, ResistanceBio, Shasqi, and Viosera Therapeutics. Endpoint Ventures is led by experienced partners with deep expertise in healthcare and life sciences. The firm offers unique value-add services such as strategic guidance, industry connections, and operational support to help their portfolio companies scale effectively and achieve their growth milestones.
Endpoint Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies9
Current Portfolio Count7
Total Portfolio Exits1
Top Investment Stages
Seed8 (88.9%)
Series A1 (11.1%)
Stage Mix
Seed 89%Series A 11%
Concentration shown as share of disclosed investments by stage.